IL17A and multiple sclerosis: Ghiasian et al., 2019 examined the potential protective effects of crocin in the multiple sclerosis patients and demonstrated a remarkable reduction in the levels of TNF‐α, interleukin 17 (IL‐17), lipid peroxidation, and DNA damage (Ghiasian et al., 2019).